TECH - BIO-TECHNE Corp

QQQ $ 612.14 $ 1.56 (0.26 %)

DIA $ 470.45 $ 1.64 (0.35 %)

SPY $ 672.31 $ 2.95 (0.44 %)

TLT $ 89.45 $ -0.19 (-0.21 %)

GLD $ 367.77 $ 0.35 (0.1 %)

Previous Close

$ 57.41

Open

$ 57.71

Bid

$ 53.81 x 1

Ask

$ 63.65 x 1

Day's Range

$ 56.53 - $ 58.04

52 Week Range

$ 45.87 - $ 78.94

Volume

1,756,126

Average Volume

Market Cap

8.95B

Beta (5Y Monthly)

$ 1.22

PE Ratio (TTM)

$ 114.70

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.01)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-05-2025	09-30-2025	10-Q
2	08-22-2025	06-30-2025	10-K
3	05-08-2025	03-31-2025	10-Q
4	02-06-2025	12-31-2024	10-Q
5	11-05-2024	09-30-2024	10-Q
6	08-22-2024	06-30-2024	10-K
7	05-06-2024	03-31-2024	10-Q
8	02-07-2024	12-31-2023	10-Q
9	11-07-2023	09-30-2023	10-Q
10	08-23-2023	06-30-2023	10-K
11	05-08-2023	03-31-2023	10-Q
12	02-07-2023	12-31-2022	10-Q
13	11-07-2022	09-30-2022	10-Q
14	08-24-2022	06-30-2022	10-K
15	05-09-2022	03-31-2022	10-Q
16	02-07-2022	12-31-2021	10-Q
17	11-08-2021	09-30-2021	10-Q
18	08-25-2021	06-30-2021	10-K
19	05-07-2021	03-31-2021	10-Q
20	02-08-2021	12-31-2020	10-Q
21	11-09-2020	09-30-2020	10-Q
22	08-26-2020	06-30-2020	10-K
23	05-11-2020	03-31-2020	10-Q
24	02-06-2020	12-31-2019	10-Q
25	11-06-2019	09-30-2019	10-Q
26	08-28-2019	06-30-2019	10-K
27	05-07-2019	03-31-2019	10-Q
28	02-07-2019	12-31-2018	10-Q
29	11-07-2018	09-30-2018	10-Q
30	08-27-2018	06-30-2018	10-K
31	05-09-2018	03-31-2018	10-Q
32	02-08-2018	12-31-2017	10-Q
33	11-09-2017	09-30-2017	10-Q
34	09-07-2017	06-30-2017	10-K
35	05-10-2017	03-31-2017	10-Q
36	02-09-2017	12-31-2016	10-Q
37	11-09-2016	09-30-2016	10-Q
38	08-29-2016	06-30-2016	10-K
39	05-10-2016	03-31-2016	10-Q
40	02-09-2016	12-31-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

UBS Maintains Buy on Bio-Techne, Raises Pr...
11/06/2025 18:03:20

UBS analyst Dan Leonard maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $65 to $70.

Wells Fargo Maintains Overweight on Bio-Te...
11/06/2025 15:47:17

Wells Fargo analyst Brandon Couillard maintains Bio-Techne (NASDAQ:TECH) with a Overweight and raises the price target from ...

Bio-Techne Q1 Adj. EPS $0.42, Inline, Sale...
11/05/2025 11:31:38

Bio-Techne (NASDAQ:TECH) reported quarterly earnings of $0.42 per share which met the analyst consensus estimate. This is uncha...

Earnings Scheduled For November 5, 2025
11/05/2025 11:12:12

An Overview of Bio-Techne's Earnings
11/04/2025 17:02:29

ScaleReady and Partners Provide Grant Fund...
10/23/2025 11:14:39

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ:TECH) and CellReady, announced four...

TD Cowen Maintains Buy on Bio-Techne, Rais...
10/14/2025 12:58:54

TD Cowen analyst Kyle Boucher maintains Bio-Techne (NASDAQ:TECH) with a Buy and raises the price target from $65 to $70.

Bio-Techne And Oxford Nanopore Expand Coll...
10/09/2025 11:25:36

Bio-Techne, Oxford Nanopore Technologies E...
10/09/2025 11:25:14

5 Analysts Assess Bio-Techne: What You Nee...
10/07/2025 22:01:25

Evercore ISI Group Maintains Outperform on...
10/07/2025 17:58:04

Evercore ISI Group analyst Daniel Markowitz maintains Bio-Techne (NASDAQ:TECH) with a Outperform and raises the price target...

trump-pfizer-deal-pushes-health-care-stocks-to-best-rally-in-5-years

Trump-Pfizer Deal Pushes Health Care Stock...
10/01/2025 20:22:35

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tari...

Bio-Techne Advances Spatial Biology Portfo...
09/26/2025 10:31:58

RNAscope™ technology and the Lunaphore COMET™ enable simultaneous RNA and protein detection on the same tissue sectionTechnolog...

bio-techne-stock-upgraded-as-analyst-flags-attractive-entry-point

Bio-Techne Stock Upgraded As Analyst Flags...
09/03/2025 18:45:40

RBC Capital upgraded Bio-Techne, citing M&A confidence, margin gains, and growth potential after a sharp stock drop and ali...

RBC Capital Upgrades Bio-Techne to Outperf...
09/03/2025 13:57:08

RBC Capital analyst Conor McNamara upgrades Bio-Techne (NASDAQ:TECH) from Sector Perform to Outperform and raises the price ...

6 Analysts Have This To Say About Bio-Techne
08/21/2025 14:02:06

Citigroup Upgrades Bio-Techne to Buy, Rais...
08/21/2025 12:45:00

Citigroup analyst Patrick Donnelly upgrades Bio-Techne (NASDAQ:TECH) from Neutral to Buy and raises the price target from $5...

RBC Capital Maintains Sector Perform on Bi...
08/07/2025 14:44:38

RBC Capital analyst Conor McNamara maintains Bio-Techne (NASDAQ:TECH) with a Sector Perform and lowers the price target from...

During Conf Call, Bio-Techne Corp Exec Rep...
08/06/2025 14:10:48

During Conf Call, Bio-Techne Corp Exec Rep...
08/06/2025 13:32:14